Growth Metrics

Catalyst Pharmaceuticals (CPRX) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 70.27%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 70.27%
Dec 31, 2025 3.85%
Sep 30, 2025 -7.74%
Jun 30, 2025 39.63%
Mar 31, 2025 92.04%
Dec 31, 2024 54.61%
Sep 30, 2024 49.73%
Jun 30, 2024 59.94%
Mar 31, 2024 103.04%
Dec 31, 2023 61.93%
Sep 30, 2023 57.96%
Jun 30, 2023 32.35%
Mar 31, 2023 18.72%
Dec 31, 2022 48.28%
Sep 30, 2022 36.43%
Jun 30, 2022 23.00%
Mar 31, 2022 45.14%
Dec 31, 2021 62.56%
Sep 30, 2021 72.38%
Jun 30, 2021 74.26%
Mar 31, 2021 37.98%
Dec 31, 2020 73.82%
Sep 30, 2020 85.17%
Jun 30, 2020 83.15%
Mar 31, 2020 56.86%
Dec 31, 2019 68.52%
Sep 30, 2019 90.94%
Jun 30, 2019 73.69%
Mar 31, 2019 -10.57%
Dec 31, 2018 -21.72%
Sep 30, 2018 -9.17%
Jun 30, 2018 -3.90%
Mar 31, 2018 -17.02%
Dec 31, 2017 -0.42%
Sep 30, 2017 9.51%
Jun 30, 2017 -2.37%
Mar 31, 2017 -16.95%
Dec 31, 2016 -2.22%
Sep 30, 2016 -24.86%
Jun 30, 2016 -33.83%
Mar 31, 2016 -38.15%
Dec 31, 2015 -42.70%
Sep 30, 2015 -69.31%
Jun 30, 2015 -54.81%
Mar 31, 2015 -42.87%
Dec 31, 2014 -40.40%
Sep 30, 2014 -41.55%
Jun 30, 2014 -26.81%
Mar 31, 2014 -42.90%
Dec 31, 2013 -75.11%
Sep 30, 2013 -27.25%